Key Advances in the Clinical Management of Skin Cancer
David Ross, Margaret Spittle
Royal Society of Medicine Press, Jan 1, 2004 - Medical - 73 pages
The aim of this title is to present important therapeutic advances in skin cancer therapy, and to provide an assessment of their likely and appropriate effect upon the management of skin cancer, both now and in the foreseeable future.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Acad Dermatol actinic keratoses actinic keratosis ALA-PDT Arch Dermatol associated At-MTB basal cell carcinoma Bowen's disease cell carcinoma BCC chemoprevention chemotherapy clearance Clin Oncol clinical conventional surgery conventional surgical cosmetic result cutaneous dacarbazine Dermatol Surg Oncol Dermatology diagnosis dose drug effect efficacy etretinate excision margins Figure follow-up genetic Gorlin syndrome histological Hospital imiquimod immunohistochemistry immunosuppression incidence incompletely excised increased interferon irradiation Kaposi sarcoma keratoses lesions lFN-a lnstitute lymph node MAL-PDT malignant melanoma melanocyte melanoma cells metastatic melanoma methylene blue micrographic surgery Mohs months neoplasms non-melanoma skin cancers overall survival particularly pathologist phase lll photodynamic therapy plastic surgeons present primary psoriasis radiation radionuclide radiotherapy randomized trial re-excision recurrence rates renal transplant reported retinoid risk sentinel node biopsy squamous cell carcinoma sun exposure superficial BCC surgical excision surgical margins survival benefit technique thalidomide therapeutic thickness topical treated tumour ultraviolet xeroderma pigmentosum